XML 24 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock Based Compensation
9 Months Ended
Dec. 28, 2012
Stock Based Compensation
Note 3.  Stock Based Compensation
 
The Company has three stock equity plans:  The 1997 Employee Stock Option Plan, the 2000 Stock Option Plan and the 2007 Equity Incentive Plan.  As of December 28, 2012, no additional awards may be issued under either the 1997 Employee Stock Option Plan or the 2000 Stock Option Plan.  There are 2,500,000 shares authorized for issuance under the 2007 Equity Incentive Plan, with 263,295 shares remaining available for future grant.

Options and restricted stock awards may be granted to employees, officers, directors and consultants.  Options typically vest over a period of one to four years and are exercisable up to ten years from the date of issuance.   The option exercise price equals the stock’s market price on the date of grant.  Restricted stock awards typically vest over a period of six months to four years, and the shares subject to such awards are generally not transferrable until the awards vest.
 
 
The following table summarizes information regarding options outstanding and options exercisable at each of the quarterly periods through the nine months ended December 30, 2011 and December 28, 2012, respectively, and the changes during the periods then ended:
 
   
Number of
Options
Outstanding
(000’s)
   
Weighted
Average
 Exercise Price
per Share
   
Number of
Shares
Exercisable
(000’s)
   
Weighted
Average
Exercise Price
per Share
 
Balance as of March 31, 2011
    2,161     $ 1.65       1,933     $ 1.74  
Granted
    368     $ 1.52                  
Exercised
    (16 )   $ 0.57                  
Expired or forfeited
    (37 )   $ 1.69                  
Balance as of July 1, 2011
    2,476     $ 1.64       1,980     $ 1.72  
Granted
    160     $ 0.95                  
Exercised
    (27 )   $ 0.83                  
Expired or forfeited
    --     $ --                  
Balance as of September 30, 2011
    2,609     $ 1.60       1,972     $ 1.74  
Granted
    --     $ --                  
Exercised
    --     $ --                  
Expired or forfeited
    --     $ --                  
Balance as of December 30, 2011
    2,609     $ 1.60       2,347     $ 1.70  
Vested & expected to Vest, December 30, 2011
    2,531     $ 1.60                  
                                 
   
Number of
Options
Outstanding
(000’s)
   
Weighted
Average
Exercise Price
per Share
   
Number of
Shares
Exercisable
(000’s)
   
Weighted
Average
Exercise Price
per Share
 
Balance as of March 31, 2012
    2,267     $ 1.75       1,994     $ 1.88  
Granted
    125     $ 0.63                  
Exercised
    (5 )   $ 0.44                  
Expired or forfeited
    (5 )   $ 0.44                  
Balance as of June 29, 2012
    2,382     $ 1.69       2,023     $ 1.86  
Granted
    67     $ 0.62                  
Exercised
    --     $ --                  
Expired or forfeited
    (11 )   $ 2.26                  
Balance as of September 28, 2012
    2,438     $ 1.66       2,058     $ 1.83  
Granted
    --     $ --                  
Exercised
    --     $ --                  
Expired or forfeited
    (31 )   $ 1.19                  
Balance as of December 28, 2012
    2,407     $ 1.67       2,085     $ 1.81  
Vested & expected to Vest, December 28, 2012
    2,353     $ 1.69                  
                                 

Information regarding stock options outstanding as of December 28, 2012 is as follows:
 
   
Options Outstanding
 Price Range
 
Shares  (in 000s)
 
Weighted
Average
Exercise Price
 
Weighted Average
Remaining Life
 $0.44 - $1.25
 
628
 
$     0.74
 
7.38
 $1.26 - $2.50
 
1,474
 
$     1.82
 
4.41
  $2.51 - $5.34
 
305
 
$     2.84
 
2.51
 
   
Options Exercisable
Price Range
 
Shares  (in 000s)
 
Weighted
Average
Exercise Price
 
Weighted Average
Remaining Life
$0.44 - $1.25
 
306
 
$     0.72
 
5.72
$1.26 - $2.50
 
1,474
 
$     1.82
 
4.41
$2.51 - $5.34
 
305
 
$     2.84
 
2.51
 
The intrinsic value of options exercised during the three and nine month periods ended December 28, 2012 was zero and $1,100, respectively.  The intrinsic value of options exercised during the three and nine month periods ended December 30, 2011 was zero and $21,132, respectively.

During the third quarter of fiscal 2012 and fiscal 2013, there were no restricted shares issued.  The restricted share transactions are summarized below:
 
   
Shares (000’s)
   
Weighted Average
Grant Date
Fair Value Per Share
 
Unvested, March 31, 2011
    70     $ 0.44  
Granted
    55     $ 1.51  
Vested
    (70 )   $ 0.44  
Expired or forfeited
    --     $ --  
Unvested, July 1, 2011
    55     $ 1.51  
Granted
    198     $ .98  
Vested
    --     $ --  
Expired or forfeited
    --     $ --  
Unvested, September 30, 2011
    253     $ 1.10  
Granted
    --     $ --  
Vested
    (55 )   $ 1.51  
Expired or forfeited
    --     $ --  
Unvested, December 30, 2011
    198     $ 0.98  

   
Shares (000’s)
   
Weighted Average
Grant Date
Fair Value Per Share
 
Unvested, March 31, 2012
    246     $ 0.84  
Granted
    --     $ --  
Vested
    --     $ --  
Expired or forfeited
    --     $ --  
Unvested, June 29, 2012
    246     $ 0.84  
Granted
    --     $ --  
Vested
    (76 )   $ 0.82  
Expired or forfeited
    --     $ --  
Unvested, September 28, 2012
    170     $ 0.84  
Granted
    --     $ --  
Vested
    --     $ --  
Expired or forfeited
    --     $ --  
Unvested, December 28, 2012
    170     $ 0.84  
 
The Company estimates the fair value of stock-based awards utilizing the Black-Scholes pricing model for stock options and using the intrinsic value for restricted stock. The fair value of the awards is amortized as compensation expense on a straight-line basis over the requisite service period of the award, which is generally the vesting period. The Black-Scholes fair value calculations involve significant judgments, assumptions, estimates and complexities that impact the amount of compensation expense to be recorded in current and future periods. The factors include:
 
1.
The time period that option awards are expected to remain outstanding has been determined based on the average of the original award period and the remaining vesting period in accordance with the SEC’s short-cut approach pursuant to SAB No. 107, “Disclosure about Fair Value of Financial Statements”. The expected term assumption for awards issued during the nine month periods ended December 28, 2012 and December 30, 2011 was 6.3 years. As additional evidence develops from the employee’s stock trading history, the expected term assumption will be refined to capture the relevant trends.
2.
The future volatility of the Company’s stock has been estimated based on the weekly stock price from the acquisition date of Picometrix (May 2, 2005) to the date of the latest stock grant. The expected volatility assumption for awards issued during both the nine month periods ended December 28, 2012 and December 30, 2011 averaged 67%. As additional evidence develops, the future volatility estimate will be refined to capture the relevant trends.
3.
A dividend yield of zero has been assumed for awards issued during nine month periods ended December 28, 2012 and December 30, 2011, based on the Company’s actual past experience and the fact that Company does not anticipate paying a dividend on its shares in the near future.
4.
The Company has based its risk-free interest rate assumption for awards issued during the nine month periods ended December 28, 2012 and December 30, 2011 on the implied yield available on U.S. Treasury issues with an equivalent expected term, which averaged 0.8% and 1.7% during each of the respective periods.
5.
The forfeiture rate, for awards issued during both the nine month periods ended December 28, 2012 and December 30, 2011, was 17% and was based on the Company’s actual historical forfeiture history.
 
The Company’s stock-based compensation expense is classified in the table below:
 
   
Three months ended
   
Nine months ended
 
   
December 28,
2012
   
December 30,
2011
   
December 28,
2012
   
December 30,
2011
 
Cost of Products Sold
  $ 3,000     $ 23,000     $ 10,000     $ 52,000  
Research, development & engineering expense
    12,000       69,000       35,000       155,000  
General and Administrative expense
    28,000       133,000       69,000       249,000  
Sales and Marketing expense
    3,000       10,000       10,000       24,000  
Total Stock Based Compensation
  $ 46,000     $ 235,000     $ 124,000     $ 480,000  
 
At December 28, 2012, the total stock-based compensation expense related to unvested stock options and restricted shares granted to employees and independent directors under the Company’s stock option plans but not yet recognized was $216,000. This expense will be amortized on a straight-line basis over a weighted-average period of approximately 2.3 years and will be adjusted for subsequent changes in estimated forfeitures.